Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Summer stem cell entertainment
It’s summertime and the living is easy. At least it was before a global pandemic happened. Hopefully you still have vacation time planned and this post offers some ideas for your downtime. The following books and shows aren’t all brand new, but they haven’t been mentioned yet on Signals. Books I confess to not having […]
Right Turn: These jokes never get old, just like the appeal of a blog carnival
Here at Signals, we are gearing up for our sixth blog carnival, to be held on Wednesday, August 25, 2021. If you’ve never read one before, Signals’ blog carnival is a collection of posts from thought leaders and influential bloggers all centred around one theme. In August, you’ll visit Signals and, through one blog post […]
Right Turn: A look at CIRM, Catapult and CCRM
Back in November 2020, California voters approved Proposition 14. That means US$5.5B is being directed to the California Institute for Regenerative Medicine (CIRM) to support promising cell and gene therapy research so the organization can continue the important work it began in 2004. Although CIRM had quite a head start and launched with very impressive […]
Comments